De Brauw advised underwriters on secondary offering of shares in NewAmsterdam Pharma. NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients...
NewAmsterdam Pharma’s USD181 Million Secondary Offering
AEGON’s Combination of its Dutch Operations with a.s.r.
De Brauw advised AEGON. Stibbe acted for Vereniging Aegon. a.s.r. was assisted by NautaDutilh. AEGON, a leading multinational life insurance, pensions and asset management company, completed...